Arpa Garay's most recent trade in Moderna Inc was a trade of 1,141 Restricted Stock Units done . Disclosure was reported to the exchange on Dec. 5, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Moderna Inc | Garay Arpa | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Dec 2023 | 1,141 | 11,405 | - | - | Restricted Stock Units | |
Moderna Inc | Garay Arpa | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Dec 2023 | 1,141 | 4,254 (0%) | 0% | - | Common Stock | |
Moderna Inc | Arpa Garay | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 78.34 per share. | 05 Dec 2023 | 564 | 3,690 (0%) | 0% | 78.3 | 44,182 | Common Stock |
Moderna Inc | Arpa Garay | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2023 | 4,562 | 13,686 | - | - | Restricted Stock Units | |
Moderna Inc | Arpa Garay | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2023 | 4,562 | 4,837 (0%) | 0% | - | Common Stock | |
Moderna Inc | Arpa Garay | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 125.75 per share. | 05 Jun 2023 | 2,290 | 2,547 (0%) | 0% | 125.8 | 287,972 | Common Stock |
Moderna Inc | Arpa Garay | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 20,040 | 20,040 | - | - | Stock Option (Right to Buy) | |
Moderna Inc | Arpa Garay | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 5,260 | 5,260 | - | - | Restricted Stock Units | |
Merck & Co Inc | Arpa Garay | SVP Human Health Global Mktg. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2022 | 21,359 | 21,359 | - | - | Stock Option (Right to Buy) | |
Merck & Co Inc | Arpa Garay | SVP Human Health Global Mktg. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2022 | 907 | 1,819 | - | - | Restricted Stock Unit | |
Merck & Co Inc | Arpa Garay | SVP Human Health Global Mktg. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 87.10 per share. | 03 May 2022 | 907 | 2,368 (0%) | 0% | 87.1 | 79,000 | Common Stock |
Merck & Co Inc | Arpa Garay | SVP Human Health Global Mktg. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2022 | 773 | 0 | - | - | Restricted Stock Unit | |
Merck & Co Inc | Arpa Garay | SVP Human Health Global Mktg. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 87.65 per share. | 03 May 2022 | 773 | 1,682 (0%) | 0% | 87.6 | 67,753 | Common Stock |
Merck & Co Inc | Arpa Garay | SVP Human Health Global Mktg. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2022 | 773 | 0 | - | - | Restricted Stock Unit | |
Merck & Co Inc | Arpa Garay | SVP Human Health Global Mktg. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 87.65 per share. | 03 May 2022 | 773 | 1,682 (0%) | 0% | 87.6 | 67,753 | Common Stock |
Merck & Co Inc | Arpa Garay | SVP Human Health Global Mktg. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.10 per share. | 03 May 2022 | 259 | 2,109 (0%) | 0% | 87.1 | 22,559 | Common Stock |
Merck & Co Inc | Arpa Garay | SVP Human Health Global Mktg. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.65 per share. | 03 May 2022 | 221 | 1,461 (0%) | 0% | 87.7 | 19,371 | Common Stock |
Merck & Co Inc | Arpa Garay | SVP Human Health Global Mktg. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.65 per share. | 03 May 2022 | 221 | 1,461 (0%) | 0% | 87.7 | 19,371 | Common Stock |
Merck & Co Inc | Arpa Garay | SVP Human Health Global Mktg. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2022 | 866 | 866 | - | - | Restricted Stock Unit | |
Merck & Co Inc | Arpa Garay | SVP Human Health Global Mktg. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 88.69 per share. | 01 May 2022 | 866 | 1,156 (0%) | 0% | 88.7 | 76,806 | Common Stock |
Merck & Co Inc | Arpa Garay | SVP Human Health Global Mktg. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.69 per share. | 01 May 2022 | 247 | 909 (0%) | 0% | 88.7 | 21,906 | Common Stock |